Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors
about
Rituximab for treating inhibitors in people with inherited severe hemophiliaBypassing agent prophylaxis in people with hemophilia A or B with inhibitorsRecombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitorsImmune tolerance induction for treating inhibitors in people with congenital haemophilia A or BRituximab for treating inhibitors in children with hemophiliaPsychological interventions for people with hemophiliaClinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentratesTreatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IXThe haemophilia certification system in CanadaInhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practicePast, present and future of hemophilia: a narrative review.Rituximab for treating inhibitors in people with inherited severe hemophilia.Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.Major surgery in severe haemophilia A with inhibitors using a recombinant factor VIIa and activated prothrombin complex concentrate hybrid regimen.The role of emicizumab, a bispecific factor IXa- and factor X-directed antibody, for the prevention of bleeding episodes in patients with hemophilia A
P2860
Q24186623-879EAF54-DF47-4E4E-AB5E-1A42AE9D5C03Q24187021-B3EEE158-BFF8-4C8E-B019-0E0F3C6BD561Q24187069-15F81B98-4512-4694-BB6C-928E7EA1A31AQ24195006-A9F053F6-2EA0-4835-83CC-A09FC715F6FAQ24197700-04A51C2C-2034-479C-8678-BC68F66E67DFQ24197868-7C7246E7-6F9B-49B2-9A19-7658C1C28CF0Q27026389-6240A10F-2F19-462A-B4B5-48408DB29484Q33608230-4BA8BEF3-9F11-4E3A-8846-16775238C175Q33708993-A3FA4921-ED35-4679-8C16-7C7D7839B1D2Q34157402-512CCF3D-F676-4D5D-8626-DF8620C7168BQ38007018-1444D21F-28CA-447F-845C-27FD0E192843Q38661525-BA6A9A0A-7898-405B-A093-2FAAFFAE34E5Q42692841-B60D1342-3DB5-4A7C-A683-701C747CCA92Q45838031-B485E9F6-F1E4-4CD8-BC7B-019F2E178608Q45862378-E354ED37-4666-4996-BFD4-67CE1F575B79Q57816367-54BBEBFC-4CE3-4FA7-BD28-4EA1DA639F17
P2860
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@ast
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@en
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@en-gb
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@nl
type
label
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@ast
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@en
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@en-gb
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@nl
prefLabel
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@ast
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@en
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@en-gb
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@nl
P2093
P2860
P1476
Recombinant Factor VIIa concen ...... ith haemophilia and inhibitors
@en
P2093
Alfonso Iorio
Davide Matino
Michael Makris
P2860
P356
10.1002/14651858.CD004449.PUB3
P577
2010-08-04T00:00:00Z